ER
$14.04
-0.45
(-3.11%)
As of Oct 22, 2026, 9:32 PM EDT · cached
Price history
Erasca Inc (ERAS) is trading down at $14.04 (-3.11%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.
IPO: July 16, 2021 · $16.00 offering · NASDAQ · View IPO details →
Erasca Inc net income history (FY2020–FY2025)
Net income
| FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Operating income | −$109.3M | −$124.9M | −$247.4M | −$141.5M | −$179.6M | −$140.9M |
| Net income | −$101.7M | −$122.8M | −$242.8M | −$125.0M | −$161.7M | −$124.5M |
| EPS (diluted) | −$4.83 | −$1.85 | −$1.99 | −$0.83 | −$0.69 | −$0.44 |
| Balance sheet | ||||||
| Cash and equivalents | $65.4M | $360.5M | $284.2M | $93.1M | $67.7M | $73.8M |
| Total assets | $124.8M | $501.4M | $514.9M | $395.3M | $502.5M | $396.2M |
| Total liabilities | $17.4M | $44.9M | $103.1M | $78.6M | $79.0M | $71.0M |
| Shareholders' equity | −$114.0M | $456.5M | $411.9M | $316.7M | $423.5M | $325.2M |
| Cash flow | ||||||
| Operating cash flow | −$32.7M | −$79.6M | −$103.3M | −$101.2M | −$109.4M | −$95.5M |
| Capital expenditure | $947.0K | $11.2M | $14.6M | $1.77M | $60.0K | $128.0K |
| Free cash flow | −$33.6M | −$90.8M | −$117.8M | −$103.0M | −$109.5M | −$95.6M |
Net income
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Operating income | −$37.2M | −$35.7M | −$35.6M | −$38.1M | −$34.5M | −$32.6M | −$187.9M | −$47.6M |
| Net income | −$31.2M | −$32.2M | −$31.0M | −$33.9M | −$30.6M | −$29.1M | −$183.4M | −$44.1M |
| EPS (diluted) | −$0.11 | −$0.06 | −$0.11 | −$0.12 | −$0.11 | −$0.10 | −$0.60 | −$0.14 |
| Balance sheet | ||||||||
| Cash and equivalents | $68.9M | $67.7M | $70.5M | $66.1M | $70.2M | $73.8M | $47.3M | $42.5M |
| Total assets | $528.9M | $502.5M | $471.2M | $445.4M | $420.4M | $396.2M | $461.2M | $435.1M |
| Total liabilities | $78.9M | $79.0M | $71.7M | $73.1M | $72.5M | $71.0M | $67.7M | $73.2M |
| Shareholders' equity | $450.0M | $423.5M | $399.5M | $372.3M | $347.9M | $325.2M | $393.5M | $361.9M |
| Cash flow | ||||||||
| Operating cash flow | −$22.4M | −$24.6M | −$31.6M | −$20.5M | −$21.7M | −$21.7M | −$27.4M | −$27.3M |
| Capital expenditure | $5.00K | $0 | $83.0K | $30.0K | $6.00K | $9.00K | $36.0K | $8.00K |
| Free cash flow | −$22.4M | −$24.6M | −$31.6M | −$20.6M | −$21.7M | −$21.7M | −$27.4M | −$27.3M |
From Erasca Inc's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
About Erasca Inc
- Headquarters
- San Diego, California From SEC filings, Oct 2026
Recent News (1)
More Health Care stocks
- ILMN Illumina
- A Agilent Technologies
- ABBV AbbVie
- ABT Abbott Laboratories
- ALGN Align Technology
- ALNY Alnylam Pharmaceuticals
- AMGN Amgen
- BAX Baxter International